Kamran Alam, Chief Financial Officer at Taysha Gene Therapies, Inc. (TSHA), sold 28,675 shares at $3.87 ($106K) on 2022-08-18, disclosed to the SEC on 2022-08-22.
Scheduled sale ($106k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.87 | 7,476 | $29K | 27.3% |
| 2 | $3.75 | 11,482 | $43K | 40.6% |
| 3 | $3.50 | 9,717 | $34K | 32.1% |
| Total | $3.70 avg | 28,675 | $106K | 100% |
| Filing → |
| TSHA | SELL | 2025-08-22 | $311K | — | Filing → |
| TSHA | SELL | 2023-08-25 | $77K | — | Filing → |
| TSHA | SELL | 2022-08-24 | $12K | — | Filing → |